SPI Healthcare
3.592,83
PKT
+39,03
PKT
+1,10
%
Werbung
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.10.22 | Roche Hold | Deutsche Bank AG | |
| 07.10.22 | Novartis Sell | Deutsche Bank AG | |
| 05.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.22 | Roche Hold | Deutsche Bank AG | |
| 04.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.09.22 | Roche Neutral | UBS AG | |
| 29.09.22 | Roche Hold | Deutsche Bank AG | |
| 29.09.22 | Roche Overweight | Barclays Capital | |
| 28.09.22 | Roche Hold | Deutsche Bank AG | |
| 26.09.22 | Novartis Neutral | UBS AG | |
| 23.09.22 | Novartis Sell | Deutsche Bank AG | |
| 23.09.22 | Novartis Underweight | Barclays Capital | |
| 23.09.22 | Novartis Underperform | Credit Suisse Group | |
| 23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.09.22 | Roche Hold | Deutsche Bank AG | |
| 21.09.22 | Novartis Sell | Deutsche Bank AG | |
| 16.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 15.09.22 | Novartis Underperform | Credit Suisse Group | |
| 15.09.22 | Roche Outperform | Credit Suisse Group | |
| 14.09.22 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.09.22 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.09.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.09.22 | Roche Hold | Deutsche Bank AG | |
| 13.09.22 | Roche Outperform | Bernstein Research | |
| 12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.09.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.09.22 | Roche Hold | Deutsche Bank AG | |
| 08.09.22 | Roche Buy | Jefferies & Company Inc. | |
| 31.08.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.08.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.08.22 | Novartis Neutral | UBS AG | |
| 25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 11.08.22 | Roche Hold | Deutsche Bank AG | |
| 10.08.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.07.22 | Roche Neutral | Credit Suisse Group | |
| 25.07.22 | Roche Neutral | JP Morgan Chase & Co. |